MCM
ALNY icon

MV Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

MV Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.2K Buy
64
+1
+2% +$340 ﹤0.01% 441
2025
Q4 		$25.1K Sell
63
-1
-2% -$443 ﹤0.01% 412
2025
Q3 		$29.2K Buy
64
+1
+2% +$407 ﹤0.01% 381
2025
Q2 		$20.5K Buy
63
+3
+5% +$830 ﹤0.01% 440
2025
Q1 		$16.2K Buy
60
+10
+20% +$2.57K ﹤0.01% 457
2024
Q4 		$11.8K Buy
50
+10
+25% +$2.63K ﹤0.01% 499
2024
Q3 		$11K Buy
40
+14
+54% +$3.65K ﹤0.01% 515
2024
Q2 		$6.32K Buy
26
+21
+420% +$3.31K ﹤0.01% 578
2024
Q1 		$748 Buy
5
+2
+67% +$334 ﹤0.01% 695
2023
Q4 		$575 Buy
+3
New +$511 ﹤0.01% 678

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return